Hemoglobin C
Hemoglobin C | |
---|---|
Specialty | Hematology |
Hemoglobin C (abbreviated as HbC) is an abnormal
HbC was discovered by Harvey Itano and James V. Neel in 1950 in two African-American families. It has since been established that it is most common among people in West Africa. It confers survival benefits as individuals with HbC are naturally resistant to malaria caused by Plasmodium falciparum, albeit incompletely.
Symptoms and signs
People with one copy of the gene for hemoglobin C (termed
Red blood cell abnormalities
The red blood cells of people with hemoglobin C disease are usually abnormally small (
Combinations with other conditions
HbC can combine with other abnormal hemoglobins and cause serious hemoglobinopathies. Individuals with sickle cell–hemoglobin C (HbSC), have inherited the gene for sickle cell disease (HbS) from one parent and the gene for hemoglobin C disease (HbC) from the other parent. Since HbC does not polymerize as readily as HbS, there is less sickling in most cases. There are fewer acute vaso-occlusive events and therefore in some cases fewer sickle cell crises. The peripheral smear demonstrates mostly target cells, occasional hemoglobin C crystals, and only a few sickle cells. However, persons with hemoglobin SC disease (HbSC) have more significant retinopathy, ischemic necrosis of bone, and priapism than those with pure SS disease.[2]
There are also a few cases of HbC in combination with HbO, HbD and beta thalassemia.[1]
Genetics
Hemoglobin C is produced when a point mutation in the
This mutated form reduces the normal plasticity of host
Resistance to malaria
Individuals with HbC have reduced risk of P. falciparum malaria infection.
Diagnosis
Physical examination may show an enlarged spleen. Tests that may be done include:
Prevention
Genetic counseling may be appropriate for high-risk couples who wish to have a baby.[14]
Treatment
Usually no treatment is needed.
Prognosis
Overall, hemoglobin C disease is one of the more
Epidemiology
Hemoglobin C is found most abundantly in areas of West Africa, such as Nigeria, where
History
Studying the molecular basis of sickle cell disease, Linus Pauling and Harvey Itano at the California Institute of Technology discovered in 1949 that the disease was due to abnormal hemoglobin called HBS.[18][19] In 1950, Itano and James V. Neel discovered from two African-American families a different blood condition very similar to sickle cell disease.[20][21] Five of the ten individuals indicated sickled RBCs. But the condition was harmless as the individuals had no anaemia. Thus, it was not clear whether it was involved in sickle cell disease. Genetically, the abnormal hemoglobin was only in heterozygous condition.[22] The next year, Neel and his colleagues established that the hemoglobin is associated with sickle cell disease.[23]
The hemoglobin was named hemoglobin III,[24] but hemoglobin C was eventually used.[25][26] By 1954, it was found that the mutant hemoglobin was highly prevalent in West Africa.[27][28] In 1960, Vernon Ingram and J. A. Hunt at the University of Cambridge discovered that the mutation was a single amino acid replacement of glutamic acid with lysine.[29]
References
- ^ license.
- ^ PMID 12818227.
- ^ PMID 15215497.
- ^ a b c d "Hemoglobin C Trait". Stjude.org. Retrieved 2015-03-03.
- ^ a b "Updating PubMed Health - National Library of Medicine - PubMed Health". Ncbi.nlm.nih.gov. 2014-11-12. Retrieved 2015-03-03.
- ^ a b c d e Hemoglobin C Disease at eMedicine
- ^ PMID 22445352.
- PMID 26019283.
- PMID 20231425.
- ^ S2CID 4360808.
- PMID 22445352.
- S2CID 4412263.
- PMID 22634344.
- ^ a b c MedlinePlus Encyclopedia: Hemoglobin C disease
- S2CID 24734397.
- PMID 12480691.
- JSTOR 2793520.
- S2CID 31674765.
- S2CID 44763460.
- PMID 13362221.
- PMID 4912473.
- PMID 14808148.
- PMID 14886398.
- PMID 13192193.
- .
- PMID 13275117.
- PMID 13187564.
- JSTOR 2793520.
- PMID 13716852.
External links
- Hemoglobin+C at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Hemoglobin+C+Disease at the U.S. National Library of Medicine Medical Subject Headings (MeSH)